Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dexter, David T.
Jenner, Peter
Schapira, Anthony H. V.
and
Marsden, C. David
1992.
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia.
Annals of Neurology,
Vol. 32,
Issue. S1,
p.
S94.
Jenner, P.
1993.
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
Acta Neurologica Scandinavica,
Vol. 87,
Issue. S146,
p.
6.
Götz, Mario E.
Künig, Gabriella
Riederer, Peter
and
Youdim, Moussa B.H.
1994.
Oxidative stress: Free radical production in neural degeneration.
Pharmacology & Therapeutics,
Vol. 63,
Issue. 1,
p.
37.
Götz, Mario E.
Künig, Gabriella
Riederer, Peter
and
Youdim, Moussa B.H.
1996.
Chemical Factors in Neural Growth, Degeneration and Repair.
p.
425.
Jenner, P.
and
Olanow, C.W.
1996.
Neurodegeneration and Neuroprotection in Parkinson's Disease.
p.
23.
Kotze, Maritha J.
de Villiers, J.Nico P.
Rooney, Roberta N.
Grobbelaar, Johanna J.
Mansvelt, Erna P.G.
Bouwens, Christianne S.H.
Carr, Jonathan
Stander, Ilse
and
du Plessis, Lana
2001.
Analysis of the NRAMP1 Gene Implicated in Iron Transport: Association with Multiple Sclerosis and Age Effects.
Blood Cells, Molecules, and Diseases,
Vol. 27,
Issue. 1,
p.
44.
Corsini, G. U.
Maggio, R.
and
Vaglini, F.
2002.
Dopamine in the CNS II.
Vol. 154 / 2,
Issue. ,
p.
321.
Chakrabarty, A
Emerson, M R
and
LeVine, S M
2003.
Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis.
Multiple Sclerosis Journal,
Vol. 9,
Issue. 4,
p.
372.
Jenner, Peter
2003.
Oxidative stress in Parkinson's disease.
Annals of Neurology,
Vol. 53,
Issue. S3,
p.
S26.
Ristić, Smiljana
Lovrečić, Luca
Brajenović-Milić, Bojana
Starčević-Čizmarević, Nada
Jazbec, Saša Šega
Sepčić, Juraj
Kapović, Miljenko
and
Peterlin, Borut
2005.
Mutations in the hemochromatosis gene (HFE) and multiple sclerosis.
Neuroscience Letters,
Vol. 383,
Issue. 3,
p.
301.
Sfagos, Constantinos
Makis, Alexandros C
Chaidos, Aristeidis
Hatzimichael, Eleftheria C
Dalamaga, Androniki
Kosma, Katerina
and
Bourantas, Konstantinos L.
2005.
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients.
Multiple Sclerosis Journal,
Vol. 11,
Issue. 3,
p.
272.
van Rensburg, S. J.
Kotze, M. J.
Hon, D.
Haug, P.
Kuyler, J.
Hendricks, M.
Botha, J.
Potocnik, F. C. V.
Matsha, T.
and
Erasmus, R. T.
2006.
Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.
Metabolic Brain Disease,
Vol. 21,
Issue. 2-3,
p.
117.
Kotze, Maritha J.
de Villiers, J Nico P
Warnich, Louise
Schmidt, Stephen
Carr, Jonathan
Mansvelt, Erna
Fourie, Elba
and
van Rensburg, Susan J
2006.
Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.
Metabolic Brain Disease,
Vol. 21,
Issue. 2-3,
p.
105.
Gellein, Kristin
Skogholt, Jon H.
Aaseth, Jan
Thoresen, Gunnar B.
Lierhagen, Syverin
Steinnes, Eiliv
Syversen, Tore
and
Flaten, Trond Peder
2008.
Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.
Journal of the Neurological Sciences,
Vol. 266,
Issue. 1-2,
p.
70.
Ramagopalan, Sreeram V.
Cukjati, Marko
Černilec, Maja
DeLuca, Gabriele C.
Dyment, David A.
Degenhardt, Alexandra
Sadovnick, A. Dessa
Šerbec, Vladka Čurin
Ebers, George C.
and
Duquette, Pierre
2008.
Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
Journal of Neuroimmunology,
Vol. 203,
Issue. 1,
p.
104.
O'Brien, Bronwyn A.
Archer, Nicholas S.
Simpson, Ann M.
Torpy, Fraser R.
and
Nassif, Najah T.
2008.
Association of SLC11A1 promoter polymorphisms with the incidence of autoimmune and inflammatory diseases: A meta-analysis.
Journal of Autoimmunity,
Vol. 31,
Issue. 1,
p.
42.
Kell, Douglas B
2009.
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.
BMC Medical Genomics,
Vol. 2,
Issue. 1,
Zivadinov, Robert
Brown, Mari Heininen-
Schirda, Claudiu V.
Poloni, Guy U.
Bergsland, Niels
Magnano, Christopher R.
Durfee, Jacqueline
Kennedy, Cheryl
Carl, Ellen
Hagemeier, Jesper
Benedict, Ralph H.B.
Weinstock-Guttman, Bianca
and
Dwyer, Michael G.
2012.
Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis.
NeuroImage,
Vol. 59,
Issue. 1,
p.
331.
Zhang, Lei
Hong, Zhongsi
Chen, Xiaoyu
Tan, Sha
Lin, Yinyao
Wang, Yanqiang
Sun, Shaoyang
Cai, Wei
and
Lu, Zhengqi
2014.
Iron Metabolism in Neuromyelitis Optica Patients.
Journal of the Neurological Sciences,
Vol. 347,
Issue. 1-2,
p.
214.
Oliveira, Sayonara Rangel
Kallaur, Ana Paula
Lopes, Josiane
Colado Simão, Andrea Name
Reiche, Edna Maria
de Almeida, Elaine Regina Delicato
Morimoto, Helena Kaminami
de Carvalho Jennings de Pereira, Wildea Lice
Alfieri, Daniela Frizon
Flauzino, Tamires
de Meleck Proença, Caio
Gomes, Anna Maria
Kaimen-Maciel, Damacio Ramón
and
Maes, Michael
2017.
Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid.
Psychiatry Research,
Vol. 250,
Issue. ,
p.
113.